| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Stanton Marshall S. | SVP, Clinical & MD Affair | 1655 ROBERTS BLVD., NW, KENNESAW | /s/ Marshall Stanton | 12 May 2025 | 0001849615 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AORT | Common Stock | Sale | $167,120 | -5,737 | -5% | $29.13 | 110,143 | 09 May 2025 | Direct | F1 |
| transaction | AORT | Common Stock | Sale | $140,145 | -4,811 | -4.4% | $29.13 | 105,332 | 09 May 2025 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Reflects weighted average price for Restricted Stock Units. Range of prices were between $28.97 to $29.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| F2 | Reflects weighted average price for Performance Stock Units. Range of prices were between $28.97 to $29.25. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |